<code id='315314B078'></code><style id='315314B078'></style>
    • <acronym id='315314B078'></acronym>
      <center id='315314B078'><center id='315314B078'><tfoot id='315314B078'></tfoot></center><abbr id='315314B078'><dir id='315314B078'><tfoot id='315314B078'></tfoot><noframes id='315314B078'>

    • <optgroup id='315314B078'><strike id='315314B078'><sup id='315314B078'></sup></strike><code id='315314B078'></code></optgroup>
        1. <b id='315314B078'><label id='315314B078'><select id='315314B078'><dt id='315314B078'><span id='315314B078'></span></dt></select></label></b><u id='315314B078'></u>
          <i id='315314B078'><strike id='315314B078'><tt id='315314B078'><pre id='315314B078'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:24439
          Three boxes of Wegovy stands in a line — coverage from STAT
          Steffen Trumpf/picture alliance/Getty Images

          WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

          Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

          advertisement

          Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Infectious disease expert Jeanne Marrazzo assumes Fauci role
          Infectious disease expert Jeanne Marrazzo assumes Fauci role

          InfectiousdiseaseexpertJeanneMarrazzowilltakeAnthonyFauci'sjobatoptheNationalInstitutesofAllergyandI

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          5 important ways Henrietta Lacks changed medical science

          HyacinthEmpinado/STATHenriettaLacks’scellshavelongbeenfamiliartoscientists—butitwastheethicalcontrov